| Product NDC: | 60429-277 |
| Proprietary Name: | Labetalol hydrochloride |
| Non Proprietary Name: | Labetalol hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; Labetalol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60429-277 |
| Labeler Name: | Golden State Medical Supply, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075133 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130416 |
| Package NDC: | 60429-277-05 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60429-277-05) |
| NDC Code | 60429-277-05 |
| Proprietary Name | Labetalol hydrochloride |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60429-277-05) |
| Product NDC | 60429-277 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130416 |
| Marketing Category Name | ANDA |
| Labeler Name | Golden State Medical Supply, Inc. |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |